Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status—United States, 1 January 2020–25 December 2021
Author(s) -
Penelope Strid,
Lauren B. Zapata,
Van T. Tong,
Laura D. Zambrano,
Kate R. Woodworth,
Aspen Riser,
Romeo R. Galang,
Suzanne M. Gilboa,
Sascha Ellington
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac479
Subject(s) - medicine , pregnancy , extracorporeal membrane oxygenation , relative risk , intensive care unit , postpartum period , confidence interval , delta , young adult , severity of illness , obstetrics , pediatrics , genetics , engineering , biology , aerospace engineering
Information on the severity of coronavirus disease 2019 (COVID-19) attributable to the Delta variant in the United States among pregnant people is limited. We assessed the risk for severe COVID-19 by pregnancy status in the period of Delta variant predominance compared with the pre-Delta period.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom